An emerging probiotic with liver health benefits for smokers  

作　　者：Wei Jia Xiaojiao Zheng 

机构地区：[1]Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus,Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200233,China [2]School of Chinese Medicine,Hong Kong Baptist University,Kowloon Tong,Hong Kong 999077,China

出　　处：《Life Metabolism》2023年第1期8-9,共2页生命（代谢（英文）

摘　　要：Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease(NAFLD).In a study recently published in Nature,Chen et al.unveiled a mechanistic role of nicotine in NAFLD progression.In addition,they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels,and thus improve nicotine-induced NAFLD phenotypes in mice.Tobacco use is a leading cause of preventable disease and death worldwide.The number of smokers worldwide has been reported to be over 1.1 billion,accounting for about 15%of the global population[1].

关 键 词：NAFLD LIVER DEATH 

分 类 号：R371[医药卫生—病原生物学]